Startups
At Kielo Research we help our clients develop innovative therapies with the patients first philosophy. We generate patient-centric evidence to support positive regulatory approval, access, and commercialization strategies. These include patient preference studies.
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 25, 2026 | Innovation Surges: Biotech Secures Major Funding, E-commerce Tech Merges | Leading biotech Oryon Cell Therapies closed a $21M Series A tranche. Total funding reached $42M. The company focuses on autologous neuron replacement for Parkinson's disease. Funding will accelerate clinical trials and manufacturing scale-u... |
| Mar 23, 2026 | Syndigo Acquires Taggstar | Syndigo, a Chicago, Illinois-based provider of product experience management (PXM) and master data management solutions, acquired Taggstar, a London, United Kingdom-based provider of AI-powered conversion rate optimization and social proof ... |
| Mar 23, 2026 | Sanius Health Acquires Kielo Research | Sanius Health, a London, UK-based provider of AI-native care management and life sciences platforms, acquired Kielo Research, a Zug, Switzerland-based provider of patient-centred research and health economics. The amount of the deal was not... |
Reviews 0
FAQ about Patient
What has the press written about Patient?
Parsers VC has collected 4 articles mentioning Patient, among them “Innovation Surges: Biotech Secures Major Funding, E-commerce Tech Merges” (Mar 25, 2026) and “Syndigo Acquires Taggstar” (Mar 23, 2026).
Is Patient still active?
Yes, Patient is active; its latest activity on Parsers VC dates from Mar 27, 2026.